TL
PFE icon

Tradewinds LLC’s Pfizer PFE Stock Holding History

Tradewinds LLC’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$508K Buy
+10,346
New +$271K 0.11% 119
2026
Q1 		– Sell
-13,089
Closed -$326K – 198
2025
Q4 		$326K Sell
13,089
-21
-0.2% -$530 0.08% 151
2025
Q3 		$334K Buy
+13,110
New +$324K 0.08% 151
2025
Q2 		– Sell
-11,423
Closed -$289K – 206
2025
Q1 		$289K Buy
11,423
+2,046
+22% +$53.5K 0.08% 163
2024
Q4 		$240K Sell
9,377
-3,533
-27% -$95.8K 0.07% 188
2024
Q3 		$374K Sell
12,910
-30
-0.2% -$875 0.12% 124
2024
Q2 		$362K Buy
+12,940
New +$356K 0.11% 140
2023
Q3 		$448K Sell
13,513
-523
-4% -$18.5K 0.26% 64
2023
Q2 		$515K Buy
14,036
+98
+0.7% +$3.81K 0.3% 55
2023
Q1 		$569K Sell
13,938
-12,439
-47% -$537K 0.34% 48
2022
Q4 		$4.77M Buy
26,377
+12,429
+89% +$596K 3.07% 6
2022
Q3 		$610K Buy
13,948
+38
+0.3% +$1.85K 0.44% 41
2022
Q2 		$729K Buy
+13,910
New +$709K 0.5% 40

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Tradewinds LLC's PFE Position: Q2 2026 in Review

Tradewinds LLC opened a new position in Pfizer (PFE) in Q2 2026: 10,346 shares worth $508K. The stake represents 0.11% of the portfolio and ranks #119 among its holdings. This is a return to the name: Tradewinds LLC previously reported a position in PFE as recently as Q4 2025.

Tradewinds LLC first reported a position in PFE in Q2 2022 and has held it in 13 quarters since. The position peaked at $4.77M in Q4 2022. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Tradewinds LLC held 10,346 shares of Pfizer worth $508K as of Q2 2026.
  • Pfizer was a new Tradewinds LLC position in Q2 2026.
  • Pfizer made up 0.11% of Tradewinds LLC's portfolio in Q2 2026, its #119 holding.
  • Tradewinds LLC first reported a position in Pfizer in Q2 2022 and has held it in 13 quarters since.
  • Tradewinds LLC's Pfizer position peaked at $4.77M in Q4 2022.
  • 2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Tradewinds LLC's 13F filing for Q2 2026, filed 14 Aug 2026.